MeMed

70 million shekels for a joint Israeli infrastructure for biological artificial intelligence models

Avi Blizovsky
July 14, 2026
2 תגובות

The IBFI consortium will attempt to create a unified representation method for molecular, cellular, and clinical data and a platform for developing models for drug discovery and personalized medicine. Partners include: Nvidia, Teva, Sheba, CytoReason, TerraCyte, and MeMed

Israel's MeMed received FDA approval to market technology for distinguishing between bacterial and viral infection

The science service
September 21, 2021
No comments

MeMed

70 million shekels for a joint Israeli infrastructure for biological artificial intelligence models

Israel's MeMed received FDA approval to market technology for distinguishing between bacterial and viral infection

Podcast: The Next Step of Evolution – The Magic of Bones

Podcast: Prof. Rafi Bistritzer on the "magic angle" in graphene and the birth of the field of twistronics

Podcast: The Great Mysteries of Science – Is There Intelligence in the Universe? (Episode 4)

New Bar-Ilan research reveals: This is how local authority budgets deepen inequality in education in Israel

Can focusing on pain actually reduce inflammation?

Young people in crisis: How are Israeli youth coping with the consequences of the coronavirus and the war?

The RNA molecule that redesigns the parasite's protein factory

The encryption method that will provide eternal protection for sensitive information